Neurocrine Biosciences, Inc. (NBIX)

129.38 +1.06 (+0.83%) USD  |  NASDAQ  |  Mar 30, 12:34
More

Neurocrine Biosciences Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for NBIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Glaukos Corp. Upgrade
Edgewise Therapeutics, Inc. Upgrade
Nuvalent, Inc. Upgrade
Agenus, Inc. Upgrade
Curis, Inc. Upgrade